Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...
Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ...
US District Judge William Alsup's restraining order has been granted on the grounds that the Office of Personnel Management ...
I envision Chiesi as a proactive leader driving innovation and collaboration within the rare disease community. Our goal is ...
Threshold Pharma is to go ahead with Phase 3 clinical trials of its only drug, TH-302, despite recent Phase 2 trials failing to show statistically significant improvement in overall survival.
The 6th TCR-based Therapies Summit returns as the only forum created solely for TCR experts pioneering best-in-class cell- ...
The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...
Use videos, photos, and other visual tools, where relevant, to help participants comprehend the information. Meet them where ...
A year after the FDA rejected its marketing application for CD20xCD3 bispecific antibody odronextamab to treat two common ...
Kyorin Pharma has signed a deal with digital health firm Hyfe to develop a digital therapeutic (DTx) for people with chronic ...
The meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) was scheduled for 13th March and was ...
These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results